Literature DB >> 16107696

NF-kappaB-repressing factor inhibits elongation of human immunodeficiency virus type 1 transcription by DRB sensitivity-inducing factor.

Ursula Dreikhausen1, Kirsten Hiebenthal-Millow, Myriam Bartels, Klaus Resch, Mahtab Nourbakhsh.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) is able to establish a latent infection during which the integrated provirus remains transcriptionally silent. In response to specific stimuli, the HIV-1 long terminal repeat (LTR) is highly activated, enhancing both transcriptional initiation and elongation. Here, we have identified a specific binding sequence of the nuclear NF-kappaB-repressing factor (NRF) within the HIV-1 LTR. The aim of this work was to define the role of NRF in regulating the LTR. Our data show that the endogenous NRF is required for transcriptional activation of the HIV-1 LTR in stimulated cells. In unstimulated cells, however, NRF inhibits HIV-1 LTR activity at the level of transcription elongation. Binding of NRF to the LTR in unstimulated cells prevents recruitment of elongation factor DRB sensitivity-inducing factor and formation of processive elongation complexes by hyperphosphorylated RNA polymerase II. Our data suggest that NRF interrupts the regulatory coupling of LTR binding factors and transcription elongation events. This inhibitory mechanism might contribute to transcriptional quiescence of integrated HIV-1 provirus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16107696      PMCID: PMC1190279          DOI: 10.1128/MCB.25.17.7473-7483.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  30 in total

Review 1.  Regulation of HIV-1 transcription.

Authors:  K A Roebuck; M Saifuddin
Journal:  Gene Expr       Date:  1999

Review 2.  Rel/NF-kappa B and I kappa B proteins: an overview.

Authors:  M J May; S Ghosh
Journal:  Semin Cancer Biol       Date:  1997-04       Impact factor: 15.707

Review 3.  HIV-1 Tat: coping with negative elongation factors.

Authors:  M E Garber; K A Jones
Journal:  Curr Opin Immunol       Date:  1999-08       Impact factor: 7.486

4.  NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation.

Authors:  Y Yamaguchi; T Takagi; T Wada; K Yano; A Furuya; S Sugimoto; J Hasegawa; H Handa
Journal:  Cell       Date:  1999-04-02       Impact factor: 41.582

5.  Constitutive silencing of IFN-beta promoter is mediated by NRF (NF-kappaB-repressing factor), a nuclear inhibitor of NF-kappaB.

Authors:  M Nourbakhsh; H Hauser
Journal:  EMBO J       Date:  1999-11-15       Impact factor: 11.598

6.  DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs.

Authors:  T Wada; T Takagi; Y Yamaguchi; A Ferdous; T Imai; S Hirose; S Sugimoto; K Yano; G A Hartzog; F Winston; S Buratowski; H Handa
Journal:  Genes Dev       Date:  1998-02-01       Impact factor: 11.361

7.  Double-stranded RNA-activated protein kinase is required for the LPS-induced activation of STAT1 inflammatory signaling in rat brain glial cells.

Authors:  Jee Hoon Lee; Eun Jung Park; Ohn Soon Kim; Hee Young Kim; Eun-Hye Joe; Ilo Jou
Journal:  Glia       Date:  2005-04-01       Impact factor: 7.452

8.  Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcription.

Authors:  Meisheng Zhou; Longwen Deng; Vincent Lacoste; Hyeon Ung Park; Anne Pumfery; Fatah Kashanchi; John N Brady; Ajit Kumar
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 9.  The sevenfold way of PKC regulation.

Authors:  W S Liu; C A Heckman
Journal:  Cell Signal       Date:  1998-09       Impact factor: 4.315

10.  The cAMP-dependent protein kinase A and protein kinase C-beta pathways synergistically interact to activate HIV-1 transcription in latently infected cells of monocyte/macrophage lineage.

Authors:  M F Rabbi; L al-Harthi; M Saifuddin; K A Roebuck
Journal:  Virology       Date:  1998-06-05       Impact factor: 3.616

View more
  6 in total

1.  Recruitment of TFIIH to the HIV LTR is a rate-limiting step in the emergence of HIV from latency.

Authors:  Young Kyeung Kim; Cyril F Bourgeois; Richard Pearson; Mudit Tyagi; Michelle J West; Julian Wong; Shwu-Yuan Wu; Cheng-Ming Chiang; Jonathan Karn
Journal:  EMBO J       Date:  2006-07-27       Impact factor: 11.598

2.  Human NF-κB repressing factor acts as a stress-regulated switch for ribosomal RNA processing and nucleolar homeostasis surveillance.

Authors:  Marta Coccia; Antonio Rossi; Anna Riccio; Edoardo Trotta; Maria Gabriella Santoro
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

3.  Differential effects of multiplicity of infection on Helicobacter pylori-induced signaling pathways and interleukin-8 gene transcription.

Authors:  Birgit Ritter; Petra Kilian; Marc Rene Reboll; Klaus Resch; Johanna Kay DiStefano; Ronald Frank; Winfried Beil; Mahtab Nourbakhsh
Journal:  J Clin Immunol       Date:  2010-10-01       Impact factor: 8.317

4.  Stromal down-regulation of macrophage CD4/CCR5 expression and NF-κB activation mediates HIV-1 non-permissiveness in intestinal macrophages.

Authors:  Ruizhong Shen; Gang Meng; Christina Ochsenbauer; Paul R Clapham; Jayleen Grams; Lea Novak; John C Kappes; Lesley E Smythies; Phillip D Smith
Journal:  PLoS Pathog       Date:  2011-05-26       Impact factor: 6.823

5.  Characterization of staufen1 ribonucleoproteins by mass spectrometry and biochemical analyses reveal the presence of diverse host proteins associated with human immunodeficiency virus type 1.

Authors:  Miroslav P Milev; Mukunthan Ravichandran; Morgan F Khan; David C Schriemer; Andrew J Mouland
Journal:  Front Microbiol       Date:  2012-10-25       Impact factor: 5.640

6.  Full-length NF-κB repressing factor contains an XRN2 binding domain.

Authors:  Jana Alexandrova; David Piñeiro; Rebekah Jukes-Jones; Ryan Mordue; Mark Stoneley; Anne E Willis
Journal:  Biochem J       Date:  2020-02-28       Impact factor: 3.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.